EN
FR
Search for:
Navigation
Services
Preclinical
Clinical
Biotesting
Regulatory
Home
About us
The company
The executive team
The facilities
Our partners
Certifications
Jobs
News & Events
News & Publications
Events
Testimonials
FAQ
Contact
News & Events
>
Events
>
Artialis will be attending the FlandersBio workshop on issues in clinical studies
Artialis will be attending the FlandersBio workshop on issues in clinical studies
Published on 04/07/2013
13
Jun
2013
Barriers to qualify a biomarker in drug development: lessons from osteoarthritis.
Biomarker-supported development of therapeutics and (companion) diagnostics adds challenges to the process of conducting clinical trials. In terms of legislation, trial set-up and sampling strategy companies are confronted with many questions, few answers and even less practical advice. Therefore FlandersBio and Eurasanté kindly invite you to participate actively in their workshop on this topic.
Barriers to qualify a
biomarker
in drug development: lessons from osteoarthritis
Yves Henrotin, Professor of Physical Therapy and Rehabilitation, Director of the Bone and Cartilage Research and President of Artialis and Synolyne / University of Liège
.
Localisation
Bio-accelerator I, Marc Van Montagu meeting room, Technologiepark 21, 9052 Zwijnaarde, Belgium
News & Publications
Events
Testimonials
© Artialis - All rights reserved
Cookie Notice
-
Privacy Policy
Made by